Department of Pharmacy, Sint Maartenskliniek, PO box 9011, 6500 GM, Nijmegen, The Netherlands.
Department of Clinical Pharmacy, Division of Laboratory and Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.
Int J Clin Pharm. 2017 Feb;39(1):196-204. doi: 10.1007/s11096-017-0424-8. Epub 2017 Jan 9.
Background Medication waste has undesirable economic and environmental consequences. This waste is partly unavoidable, but might be reduced by redispensing medicines unused by patients. However, there is little knowledge of stakeholders' views on the redispensing. Objective To identify the stakeholders' views on the redispensing of medicines unused by patients. Setting Dutch healthcare system. Method Semi-structured interviews were conducted with 19 Dutch stakeholders from September 2014 until April 2015. The interview guide included two themes: medication waste and redispensing of unused medicines. The latter included qualitative-, legal- and financial aspects and stakeholder involvement, with specific attention to the patient. Interview transcripts were subjected to thematic content analysis. Main outcome measure Requirements related to the redispensing of unused medicines. Results All stakeholders considered the redispensing of medicines desirable if the implementation is feasible and the requirements for the safe redispensing are met. All of them pointed out that the product quality of redispensed medicines should be guaranteed and that it should be clear who is responsible for the quality of redispensed medicines. The stakeholders stated that transparent communication to patients is essential to guarantee trust in the redispensing system and that patients should be willing to use redispensed medicines. Moreover, the redispensing system's benefits should outweigh the costs and a minimal economic value of medicines suitable for redispensing should be determined. Conclusion Redispensing unused medicines could decrease medication waste if several requirements are met. For successful implementation of a redispensing system, all relevant stakeholders should be involved and cooperate as a joint-force.
背景 药物浪费会产生不良的经济和环境后果。这种浪费在一定程度上是不可避免的，但可以通过重新分配患者未使用的药物来减少。然而，对于利益相关者对重新分配药物的看法知之甚少。
目的 确定利益相关者对重新分配患者未使用的药物的看法。
设置 荷兰医疗保健系统。
方法 2014 年 9 月至 2015 年 4 月，对 19 名来自荷兰的利益相关者进行了半结构化访谈。访谈指南包括两个主题：药物浪费和重新分配未使用的药物。后者包括定性、法律和财务方面以及利益相关者的参与，特别关注患者。采访记录进行了主题内容分析。
主要结果措施 与重新分配未使用的药物相关的要求。
结果 所有利益相关者都认为，如果实施可行且符合安全重新分配的要求，重新分配药物是可取的。他们都指出，重新分配药物的产品质量应得到保证，应明确谁对重新分配药物的质量负责。利益相关者表示，向患者进行透明沟通对于保证对重新分配系统的信任至关重要，并且患者应该愿意使用重新分配的药物。此外，重新分配系统的收益必须超过成本，并且应确定适合重新分配的药物的最低经济价值。
结论 如果满足几个要求，重新分配未使用的药物可以减少药物浪费。为了成功实施重新分配系统，所有相关利益相关者都应参与并作为一个联合力量进行合作。
